This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
The deal gives the Swiss pharma access to an experimental amylin-targeting treat...
Harbour BioMed created Élancé Therapeutics to develop bispecific antibody drugs ...
The deal gives the Swiss pharma access to an experimental amylin-targeting treat...
Funded by investors such as Flagship and General Catalyst, the AI startup claims...
Ionis’ drug, sapablursen, is currently being tested in a Phase 2 trial in patien...
The president’s deregulatory agenda will mean more responsibility rests on healt...
The biotech will commit $150 million to an alliance that hands it significant pr...
Unveiling of the new factory comes as Merck and other pharma companies face pres...
Trial results show vepdegestrant, a protein-degrading drug Arvinas is developing...
The deal ends 2Seventy’s short run as an independent company, during which it re...
The deal ends 2Seventy’s short run as an independent company, during which it re...
While initial study results suggest Beam's technology can correct alpha-1 antitr...
A study in people with obesity and diabetes again found CagriSema helps people l...
Findings from a pair of studies in tough-to-treat hypertension establish Mineral...
Development strategies designed to reduce the unknowns so that cell and gene the...
Enhancing manufacturability is crucial for reducing the risks associated with sc...
Analysts say the decision is a “big blow” to a once-promising class of brain the...
The struggling retail pharmacy chain entered an agreement to be purchased by pri...
The Swiss pharma will base cardiometabolic drug research at the new Allston site...
CBO Abbas Kazimi will replace longtime CEO Jeb Keiper as part of a planned leade...
Optum, the pharmacy benefit manager owned by UnitedHealth Group, placed Journavx...
The Johns Hopkins surgeon highlighted rapid growth at the agency, but pledged ke...
Questioned by senators at a Thursday hearing, President Trump's FDA nominee said...
A District Court judge issued a nationwide preliminary injunction against the ad...